Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

As the nation marks 250 years since the signing of the Declaration of Independence, the Smithsonian invites educators to ...

Integrating humanities into AI development is vital because societal impact is shaped by those who understand meaning, not just builders.

The major A.I. companies keep telling us how dangerous their new models can be, yet they must keep on building them.

Anthropic is urging its rivals to pursue an unprecedented regime of AI arms control. The explosive advances in the company’s ...

Using digital health tools to collect RWE could revolutionise care, but systemic challenges complicate the path to success.

AI safety researcher resignation at OpenAI and Anthropic proved prescient: ChatGPT ads now target users based on private chat ...

Our genetic heritage is not a blueprint or an algorithm, as many biologists have imagined, but something else entirely.

Spread the love“`html The landscape of artificial intelligence is constantly evolving, and the idea of Recursive Self-Improvement (RSI) is gaining traction as a potential game-changer. With ...

The Escalating Demand for a Business Insolvency Risk Assessment Given the current economic landscape in the UK—characterized by persistent inflation and post-Brexit market shifts—corporate failure ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.18, moving -3.34% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.57%.